Home About Us Contact Us

 

Table of Content - Volume 9 Issue 3 - March 2018


 

A case of Fahr’s Disease - A bright brain

 

Dona Das1*, P Chinnaiyan2, Dinesh Raghav3

 

1Post Graduate, 2Professor, 3Assistant Professor, Department of General Medicine, Shri Balaji Vidhyapeeth- Shri Sathya Sai Medical College and Research Institute Ammapettai, Kancheepuram, Tamil Nadu, INDIA.

Email: donad35@gmail.com

 

Abstract              Background: The term “Farh’s disease” was first coined by Karl Theodore Fahr in 1930. As seen in medical literature, this disease is predominantly autosomal dominant in inheritance as compared to autosomal recessive1.Fahr’s disease is a rare neurological disorder often characterized by neuropsychiatric behavior, Parkinsonian type movement disturbances and symmetrical calcification of the basal ganglia and dentate nucleus in the cerebellum2. We report a case of Fahr’s Disease in a 60 year old female.

Key Word: Fahr’s Disease.

 

CASE REPORT

A 60 year old, South Indian female (non alcoholic, non smoker) presented with progressive slurring of speech, ataxia and chronic headache. She also reported one suicidal attempt in the last 4 months. There was no history of seizures, trauma, or any previous history of any psychiatric or other illness. Disorientation to time, place and person was occasionally present and obeyed verbal commands.

Figure 1: Showing bilateral calcification of the basal ganglia (axial view)

Blood pressure recorded was within normal limits. Cranial nerve examination showed no deficit. No sensory loss was present. Motor examination revealed normal power, with no muscle wasting and no exaggeration of reflexes. Patient had a wide stepping gait, with slurring of speech which was incoherent. Other cerebellar signs were tested negative. Remote memory was lost. Patient also reported history auditory hallucinations.

Figure 2: Shows bilateral calcification of dentate nucleus of cerebellum

­­Patient’s blood counts were in normal limits, renal profile, lipid profile, serum calcium, serum parathyroid hormone, thyroid function tests were normal. Chest x-ray and ECG were normal. CT brain showed bilateral calcification of the basal ganglia and dentate nuclus of cerebellum. With the patient’s clinical history and normal blood profile and CT brain findings, a diagnosis of Fahr’s disease was established and was treated with benzodiazepines.

 

DISCUSSION

Fahr’s disease is a rare condition and often mimics symptoms of other psychiatric or neurological disorders. As the basal ganglia and dentate nuclei are always involved in a symmetrical pattern, the term Bilateral Striopallidodentate Calcinosis (BSPDC) was given3. Presenting symptoms like pill rolling tremors, gait disturbances, rigidity often confuse clinicians with an alternative diagnosis of Parkinson’s. An effective diagnosis of Fahr’s disease is made based on a thorough clinical history, neurological examination, brain imaging and blood biochemistry to rule out other differentials. Patients should be screened for toxins, serum parathyroid hormones, serum calcium levels to exclude hyperparathyroidism or pseudo-hypoparathyroidism. Our Patient was put on levodopa but was not effective, but benzodiazepenesdid help over time4.

 

CONCLUSION

Though the cause of Fahr’s Disease is not well established and with no definitive cure as of date, a detailed clinical history, brain imaging scans and blood investigations and a vigilant approach can help clinicians to make an early diagnosis and start with symptomatic management so that patients can lead a near to normal life as studies go on to find a cure. Typically, symptoms begin between 30-60 years of age group. The clinical evolution is that of a degenerative disorder, rather than a developmental disorder. Fahr’s disease has a prognosis difficult to establish and explain.

 

ACKNOWLEDGEMENT

The completion of this undertaking could not have been possible without the cooperation of my patient, guidance and assistance of my co-authors. Their contributions are sincerely appreciated. To all relatives, friends and family who in one way or another showed their support, thank you.

 

REFERENCES

  1. Malik R, Pandya VK, Naik D. Fahr’s Disease: a rare neurodegenerative disorder. Ind J Radiol Imag 2004; 14 (4): 383-4.
  2. Shoyama M, Ketabata Y, Kaku T, Shinosaki K. Evaluation of regional cerebral blood flow in Fahr’s disease with schizophrenia like psychosis; A case report. Am J Neuroradiol 2005; 26: 2527-9.
  3.  Manyam BV. Bilateral strio-pallido-dentate calcinosis: a proposed classification of genetic and secondary causes. Mov Disorder 1990; 5 (supl): 94S.
  4. Albanese A, Di Giovanni M, Lalli S. Dystonia: diagnosis and management. European journal of neurology. 2018 Jul 23
  5. Fahr’s syndrome: a rare clinico-radiologic entit
  6. RajulRastogi, AK Singh, UC Rastogi#, Chander Mohan, VaibhavRastogi

 


 


 

 

 



 



 



 






 





 



 



 



 




 

 


 


 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.